ReviewPLoS pathogens2009
The past and future of tuberculosis research.
Review in PLoS pathogens, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
79 citing papers in PubMed.
- Trial
- Human genetic ancestry,eLife · 2026Article
- Geospatial analysis of shared risks for tuberculosis transmission in an urban cohort.Scientific reports · 2025Article
- Multi-target Compounds against Trypanosomatid Parasites andCurrent drug targets · 2024Review
- Lessons for TB from the COVID-19 response: qualitative data from Brazil, India and South Africa.Public health action · 2023Article
- Genetic diversity ofHeliyon · 2023Article
- Mycobacterium Time-Series Genome Analysis Identifies AAC2' as a Potential Drug Target with Naloxone Showing Potential Bait Drug Synergism.Molecules (Basel, Switzerland) · 2022Article
- Silver nanoparticles synthesized from the seaweed Sargassum polycystum and screening for their biological potential.Scientific reports · 2022Article
- Fine-grain population structure and transmission patterns ofMicrobial genomics · 2022Article
- Identification of Concomitant Inhibitors against Glutamine Synthetase and Isocitrate Lyase inBioMed research international · 2022Article
- Spoligotyping of Clinical Isolates ofFrontiers in public health · 2022Article
- The Epistatic Landscape of Antibiotic Resistance of Different Clades ofAntibiotics (Basel, Switzerland) · 2021Article
- Multispacer Sequence Typing forFrontiers in veterinary science · 2021Article
- Development and application of affordable SNP typing approaches to genotype Mycobacterium tuberculosis complex strains in low and high burden countries.Scientific reports · 2019Article
- Shared Pathogenomic Patterns Characterize a New Phylotype, Revealing Transition toward Host-Adaptation Long before Speciation of Mycobacterium tuberculosis.Genome biology and evolution · 2019Article
- Quinolone-isoniazid hybrids: synthesis and preliminaryMedChemComm · 2019Article
- A Call for Systems Epidemiology to Tackle the Complexity of Schistosomiasis, Its Control, and Its Elimination.Tropical medicine and infectious disease · 2019Article
- Molecular drug susceptibility testing and strain typing of tuberculosis by DNA hybridization.PloS one · 2019Article
- Genomic sequencing is required for identification of tuberculosis transmission in Hawaii.BMC infectious diseases · 2018Article
- Ecology and evolution of Mycobacterium tuberculosis.Nature reviews. Microbiology · 2018Review
19 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Renewed efforts in tuberculosis (TB) research have led to important new insights into the biology and epidemiology of this devastating disease. Yet, in the face of the modern epidemics of HIV/AIDS, diabetes, and multidrug resistance--all of which contribute to susceptibility to TB--global control of the disease will remain a formidable challenge for years to come. New high-throughput genomics technologies are already contributing to studies of TB's epidemiology, comparative genomics, evolution, and host-pathogen interaction. We argue here, however, that new multidisciplinary approaches--especially the integration of epidemiology with systems biology in what we call "systems epidemiology"--will be required to eliminate TB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.